Decision to Issue Convertible Bonds for Supreme Court Lawsuit Settlement

On April 28, 2026, GemVax decided to issue convertible bonds (CB) to fund a settlement with Biovill related to a Supreme Court lawsuit (Case No. 2026Da 202990)
The CB includes a put option allowing early redemption at 100% of face value every three months starting from May 6, 2027
Specific terms such as conversion price, issue size, interest rates, and maturity date were not disclosed in this filing

ADVERTISEMENT (250px+)